Hurum Co. Ltd.
KKRX:3531902,165.00
KRW
+166.00
(+8.30%)
ISIN
KR7353190002
Return %
Stock
S&P 500
1Y
-45.12
14.39
3Y
-56.22
81.42
5Y
-77.39
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Jin-Seok Kim
- Full Time Employees
- 139
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Seoul South Korea
- IPO Date
- Jun 17, 2020
- Website
- hurumcorp.com
- Similar Companies
- Business
- Hurum Co., Ltd. is a South Korea-based bio-health and nutraceutical company primarily engaged in the research, development, manufacturing, and distribution of health functional foods, dietary supplements, and proprietary functional raw materials. Founded in 2005 and headquartered in Seoul, South Korea, with manufacturing and research facilities in Cheongju, Chungcheongbuk-do, the company operates across business-to-consumer (B2C) and business-to-business (B2B) segments. Its core product and service offerings comprise dietary supplements and functional nutrition products, including probiotics, lactoferrin, and gut microbiome formulations marketed under brand lines such as Yogurberry and I'm Bio; joint and bone care supplements containing Boswellia and MSM; life-stage wellness solutions, including women's menopause management and red ginseng extracts; liver care products formulated with milk thistle; eye health supplements featuring lutein; and specialized diet and inner beauty foods; alongside original equipment manufacturing (OEM), original design manufacturing (ODM), and custom ingredient extraction services utilizing proprietary natural fermentation technologies. The company sells its products through diverse domestic distribution channels, including online commerce platforms, TV home shopping networks, pharmacies, duty-free stores, and major retailers, while maintaining export operations across North America, Japan, China, and Southeast Asia. In recent developments, Hurum completed its public listing on the KOSDAQ market via a merger with a special purpose acquisition company, accelerated its clinical research investments into government-certified individually recognized functional ingredients, broadened its strategic OEM/ODM partnerships across overseas wellness markets, and expanded its commercial portfolio through the launch of next-generation postbiotic supplements and personalized health functional food product lines.